Pharmaceuticals & Therapeutics

The supplement maker's top-tier safety certification and recent acquisition signal a strategic push for market dominance and unparalleled consumer trust.

A new report reveals the staggering financial and human cost of treatment-resistant depression, highlighting massive gaps in patient and caregiver support.

Dwayne Johnson's PAPATUI launches a prestige cologne line at Target. With top perfumers and a $40 price, can it redefine men's luxury?

Groundbreaking research on new drug classes, the gut-brain axis, and personalized medicine will be unveiled at the upcoming American Headache Society meeting.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

The 'It's Always Sunny' creators' Four Walls whiskey partners with Jesse Bongiovi's Lily Pond Group, aiming to scale with celebrity power and cultural savvy.

Sensorium Therapeutics advances SNTX-2643, a novel anxiety drug, while adding a new CMO and an expert advisory board to guide its clinical journey.

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

ITG Brands acquires innovator Black Buffalo for $150M, diversifying beyond nicotine pouches to capture a new segment of smokeless alternative users.

Positive Phase 3 data for oral drug filgotinib offers new hope for thousands of axial spondyloarthritis patients who fail to respond to current therapies.

A lawsuit has been filed against The Kebab Shop after a severe E. coli outbreak left a child with kidney failure, placing the chain and its supplier under fire.

As fatal opioid overdoses triple, a new mobile treatment clinic arrives in Ellensburg, offering a crucial lifeline and eliminating a major barrier to care.

Amid a S$50B construction surge, one firm's logistics overhaul and green tech pivot reveal the strategy needed to power Singapore's ambitious future.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

Amid promising safety signals, Kazia Therapeutics expands its trial for paxalisib in TNBC, a strategic move offering new hope for a hard-to-treat cancer.

A new telehealth platform offers prescription-only CBD, navigating a major regulatory shift that will reshape the entire cannabis industry. Here's what's next.

With over 28,000 attendees, Toronto's Living Luxe Design Show redefined luxury, focusing on wellness, experience, and personalization over mere possession.

Growth equity firm AVANT BIO adds biomanufacturing legends Maik Jornitz and Lukas Utiger, signaling a shift toward deep operational support for its startups.

A landmark Novo Nordisk study finds 2 in 5 heart patients have hidden inflammation, a major risk for heart attack and stroke despite standard treatments.

Guerbet appoints independent Chairman Antoine Fady and new directors, signaling a strategic shift as the medical imaging giant celebrates its centenary.